Skip to main content
LCTX logo

LCTX · Lineage Cell Therapeutics, Inc.

Track LCTX — free
$1.08 -0.02 (-1.82%) At close · Sep 4
Market Cap
$273.14M
Shares
252.91M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 131
Total Value: $152,784,679
Total Shares: 116,629,578
Showing 1–100 of 134 holdings by value · page 1 of 2

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 131 13F filers · Δ vs Mar 31, 2026
Top Holder
42.5%
Sep 2023 → Jun 2026 · range 38.9% – 56.2%
−1.8 pts
Top 5
71.8%
Sep 2023 → Jun 2026 · range 67.5% – 80.7%
+4.2 pts
Top 10
86.2%
Sep 2023 → Jun 2026 · range 83.0% – 91.1%
+3.2 pts
HHI
2,104
Sep 2023 → Jun 2026 · range 1,817 – 3,361
Moderately concentrated−64

Quarterly Activity

vs Mar 31, 2026
New
36
Increased
25
Decreased
28
Sold Out
36
Unchanged
42
Holder count: 0
Institutional value: -13.5%
Shares held: +4.3%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 134
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 876343 CUSIP 53566P109 13F (30d) 79 filings 79 filers Visit website Investor relations